Considering that one critical way by which CTLs kill tumor cells is through the release of cytotoxic molecules into the immune synapse that they form, it was speculated that the delivery of GSDMD and GzmB into effector cancer cells may have been the mechanism underlying CTL cytotoxicity seen in this study [71]. The gene discussed is GSDMD; the disease is neoplasm.